Who is sponsoring NCT03221504?

NCT03221504 is sponsored by Medical University of Warsaw.

What drugs are being tested in NCT03221504?

Interventions in NCT03221504: Longer therapy duration, Shorter therapy duration.

What condition does NCT03221504 study?

NCT03221504 studies Urinary Tract Infections in Children.

Is NCT03221504 still recruiting?

NCT03221504 is currently status unknown. Last updated 20 March 2018.

Last reviewed 2018-03-20 · How we verify

NCT03221504

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

7-day Compared With 10-day Antibiotic Treatment for Febrile Urinary Tract Infections in Children

Status unknown NA Last updated 20 March 2018

What this trial tests

NA trial testing Longer therapy duration in Urinary Tract Infections in Children in 221 participants. Status unknown.

Timeline

1 January 2018

Primary endpoint
31 July 2019

31 January 2020

Quick facts

Lead sponsor	Medical University of Warsaw
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	treatment
Enrollment	221
Start date	1 January 2018
Primary completion	31 July 2019
Estimated completion	31 January 2020
Sites	2 locations across Poland

Drugs / interventions tested

Longer therapy duration
Shorter therapy duration

Conditions studied

Urinary Tract Infections in Children — all drugs for Urinary Tract Infections in Children →

Sponsor

Medical University of Warsaw

Who can join

Adults 3 Months to 7, any sex, with Urinary Tract Infections in Children. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The investigators aim to assess the effectiveness of a 7-day compared with a 10-day course of antibiotic treatment for febrile urinary tract infections (UTIs) in children. It is formulated a hypothesis that a 7-day course of antibiotic therapy is equally effective as a 10-day course of therapy and would entail a lower risk of adverse events and better compliance.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

7-day compared with 10-day antibiotic treatment for febrile urinary tract infections in children: protocol of a randomised controlled trial.
Daniel M, Szajewska H, Pańczyk-Tomaszewska M. · · 2018 · cited 7× · PMID 29500209 · DOI 10.1136/bmjopen-2017-019479
Shorter treatments for (febrile) urinary tract infections: are we there?
Tramper-Stranders GA. · · 2025 · PMID 39944877 · DOI 10.21037/tp-24-447

Verify or expand the search:

Other trials of Longer therapy duration

Trials testing the same drug.

NCT01994538 — Seven vs. 14 Days Treatment for Male Urinary Tract Infection · NA · completed

Other recruiting trials for Urinary Tract Infections in Children

Currently open trials in the same condition.

NCT05819229 — Oral Antibiotics Alone in Children Aged 4 Weeks to 2 Months With a Urinary Tract Infection · recruiting

Other Medical University of Warsaw trials

Trials by the same sponsor.

NCT07515768 — TAVI Without On-Site Cardiac Surgery in Poland: A Randomized Multicenter Trial Protocol · NA · not yet recruiting
NCT07511907 — Routine Intraoperative White Test for Bile Leak Detection in Liver Resection · NA · not yet recruiting
NCT07498660 — PRP Injection Into the Sacroiliac Joint After Ipsilateral THA: Effects on Early Recovery and Function (SIJ-THA Randomize · NA · not yet recruiting
NCT07398898 — Use of Augmented Reality Glasses and Noise-Cancelling Headphones to Reduce Dental Anxiety in Adult Patients · NA · recruiting
NCT07237204 — 15 vs 45 Minute Pringle Maneuver in Liver Cancer Resection: Randomized Noninferiority Trial · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03221504 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Medical University of Warsaw
Last refreshed: 20 March 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03221504.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing